Cargando…
Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections
Acinetobacter baumannii has among the highest rates of antibiotic resistance encountered in hospitals. New therapies are critically needed. We found that rifabutin has previously unrecognized hyperactivity against most strains of A. baumannii. Here we review the pharmacology and adverse effects of r...
Autores principales: | Phillips, Matthew C, Wald-Dickler, Noah, Loomis, Katherine, Luna, Brian M, Spellberg, Brad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651144/ https://www.ncbi.nlm.nih.gov/pubmed/33204754 http://dx.doi.org/10.1093/ofid/ofaa460 |
Ejemplares similares
-
Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
por: Cheng, Jiaqi, et al.
Publicado: (2021) -
In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021) -
A Nutrient-limited Screen Unmasks Rifabutin Hyperactivity for XDR Acinetobacter baumannii
por: Luna, B., et al.
Publicado: (2020) -
Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome
por: Maeusli, Marlène, et al.
Publicado: (2020) -
In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
por: Trebosc, Vincent, et al.
Publicado: (2020)